Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1983-03-04
1985-07-09
Schwartz, Richard A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548318, A61K 31415, C07D40306
Patent
active
045282978
ABSTRACT:
New 3-azetidinylethyl-1-phenyl-2-imidazolidinones with neuroleptic activity, their use and methods for their preparation. The azetidinyl group bears alkyl substituents in position 3 and the phenyl group bears halogenated substituents in position 3 and hydroxy group or acylated hydroxy groups in position 4 and/or 6.
REFERENCES:
patent: 4011238 (1977-03-01), Fontanella et al.
Assandri Alessandro
Fontanella Luigi
Martinelli Edoardo
Gruppo Lepetit S.p.A.
Macchetta Francesco
Nesbitt Stephen L.
Schwartz Richard A.
Stein William J.
LandOfFree
Neuroleptic 3-azetidinylethyl-1-phenyl-2-imidazolidinones does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Neuroleptic 3-azetidinylethyl-1-phenyl-2-imidazolidinones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Neuroleptic 3-azetidinylethyl-1-phenyl-2-imidazolidinones will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-909548